Drug Discovery & Pharmaceuticals

RSS

Developing the Next Generation of Water-soluble DREADDs

An interview with James Flanaghan, discussing the uses of DREADDs in neurobiological research and the advantages of water-soluble ligands.

From Hello Bio 19 Dec 2018

Researchers discover how MAPK translocation leads to drug resistance in melanoma

Researchers have discovered that the ER translocation of MAPK leads to drug resistance in melanoma.

18 Dec 2018

National Biofilms Innovation Centre award grant to Neem Biotech for novel anti-biofilm drug development

Neem Biotech, Welsh Wound Innovation Centre and Sheffield Collaboratorium for Antimicrobial Resistance and Biofilms Awarded NBIC Grant to Advance Development of Neem’s First-in-Class Treatments for Wound Infections.

From Neem Biotech 17 Dec 2018

Getting the Most Out of the CLARITY Technique

An interview with Dr. Tim Steppe, discussing the latest advances in the CLARITY technique and his top tips for scientists using this method in their research.

From Logos Biosystems 17 Dec 2018

Answering the Biggest Neurological Research Questions of Today

An interview with Dr. Peggy Taylor, discussing the biggest neurological research questions of today and how BioLegend is helping to develop new biomarkers for neurological disease.

From BioLegend 14 Dec 2018

New discovery will improve the safety and predictability of CRISPR

Scientists have discovered a simple set of rules that can be used to precisely predict how DNA will be modified by the CRISPR gene editing technique.

13 Dec 2018

Microbiological analysis of bacteria that cause food poisoning could save lives

Researchers have made an important discovery that could help save patients with bacterial infections, particularly those suffering from food poisoning.

12 Dec 2018

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

Dr. John McCafferty celebrates the success of phage display technology with Nobel Prize in Chemistry Laureates.

From FairJourney Biologics 12 Dec 2018

Integral Molecular and Merus collaborate to develop bispecific antibody therapeutics

Integral Molecular, the industry leader in the discovery of monoclonal antibodies against membrane proteins, and Merus N.V., a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics, announced that they have entered into a collaboration on multiple undisclosed targets.

12 Dec 2018

Customizing Genetically Engineered Models for Specific Research Applications

In this interview conducted at SfN 2018, Philip Dubé from Taconic Biosciences, goes into detail about genetically engineered models and their importance in understanding neurodegenerative diseases.

From Taconic Biosciences, Inc. 4 Dec 2018

Absolute Antibody announces major new expansion

Antibody specialist Absolute Antibody Ltd has announced a major new expansion to its site in North East England. The company opened a production facility in the area just two years after it was founded in Oxford in 2012, and has undergone rapid expansion since then.

From Absolute Antibody 4 Dec 2018

Insights from the Shunde Biomedical Industry Investment Promotion Conference

From November 14-17, the 2018 Shunde Biomedical Industry Investment Promotion Conference was successfully held at the Ramada Plaza Hotel, Shunde, GuangDong, China

From Aurora Biomed Inc. 29 Nov 2018

Researchers create largest publicly available virtual library of macrolide scaffolds

Researchers from North Carolina State University have created the largest publicly available virtual library of macrolide scaffolds. The library - called V1M - contains chemical structures and computed properties for 1 million macrolide scaffolds with potential for use as antibiotics or cancer drugs.

29 Nov 2018